- Filed
- May 12, 2020 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · May 4, 2020 | 12.21M sh |
| Shares Diluted | Q1 2020 · Mar 31, 2020 | 12.1M sh |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 12.36M sh |
| Capex | Q1 2020 · Mar 31, 2020 | $1.06M |
| Capex | Q1 2020 · Mar 31, 2019 | $372K |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | $4.41M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | −$12.25M |
| Long Term Debt | Q1 2020 · Mar 31, 2020 | $101.93M |
| Long Term Debt | Q1 2020 · Dec 31, 2019 | $74.93M |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $42.26M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $15.7M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $16.51M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $21.28M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $121.36M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $99.15M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $88.69M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $69.21M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $175.56M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $157.34M |
| Eps Diluted | Q1 2020 · Mar 31, 2020 | −$0.15 |
| Eps Diluted | Q1 2020 · Mar 31, 2019 | $0.05 |
| Eps Basic | Q1 2020 · Mar 31, 2020 | −$0.15 |
| Eps Basic | Q1 2020 · Mar 31, 2019 | $0.05 |
| Sga Expense | Q1 2020 · Mar 31, 2020 | $5.94M |
| Sga Expense | Q1 2020 · Mar 31, 2019 | $6.23M |
| Net Income | Q1 2020 · Mar 31, 2020 | −$789K |
| Net Income | Q1 2020 · Mar 31, 2019 | $1.6M |
| Operating Income | Q1 2020 · Mar 31, 2020 | $819K |
| Operating Income | Q1 2020 · Mar 31, 2019 | $2.71M |
| Gross Profit | Q1 2020 · Mar 31, 2020 | $7.96M |
| Gross Profit | Q1 2020 · Mar 31, 2019 | $10.02M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2020 | $60.53M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2019 | $80.35M |
| Revenue | Q1 2020 · Mar 31, 2020 | $68.48M |
| Revenue | Q1 2020 · Mar 31, 2019 | $90.38M |